[{"NetIncomeLossConverted_3_Q3_USD":-127158000.0,"NetIncomeLossConverted_1_Q3_USD":-65848000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-87723000.0,"CommonStockSharesOutstanding_0_Q3_shares":105599976.0,"StockholdersEquity_0_Q3_USD":825080000.0,"EarningsPerShareBasic_1_Q3_USD":-0.65,"EarningsPerShareBasic_3_Q3_USD":-1.28,"RevenuesConverted_1_Q3_USD":71817000.0,"RevenuesConverted_3_Q3_USD":186627000.0,"Assets_0_Q3_USD":1042544000.0,"CommonStockSharesConverted_0_Q3_shares":105599976.0,"Ticker":"TXG","CIK":"1770787","name":"10X GENOMICS, INC.","OfficialName":"10x Genomics Inc. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"7189353166.0","Country":"United States","Sector":"Health Care","Industry":"Managed Health Care","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]